U01CA239373
Cooperative Agreement
Overview
Grant Description
Optimizing GVHD prevention with systems pharmacology models.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
California
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 384% from $619,546 to $2,995,556.
Beckman Research Institute Of The City Of Hope was awarded
Optimizing GVHD Prevention with Systems Pharmacology Models
Cooperative Agreement U01CA239373
worth $2,995,556
from National Cancer Institute in June 2019 with work to be completed primarily in California United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.395 Cancer Treatment Research.
The Cooperative Agreement was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 12/21/23
Period of Performance
6/1/19
Start Date
5/31/24
End Date
Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01CA239373
Transaction History
Modifications to U01CA239373
Additional Detail
Award ID FAIN
U01CA239373
SAI Number
U01CA239373-564360608
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Funding Office
75NC00 NIH NATIONAL CANCER INSTITUTE
Awardee UEI
NPH1VN32EWN5
Awardee CAGE
069R2
Performance District
CA-32
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Cancer Institute, National Institutes of Health, Health and Human Services (075-0849) | Health research and training | Grants, subsidies, and contributions (41.0) | $3,015,099 | 100% |
Modified: 12/21/23